INTERNATIONAL PATENT: INDAPTA THERAPEUTICS, INC. FILES APPLICATION FOR "TREATMENT OF AUTOIMMUNE DISEASES OR CONDITIONS WITH NATURAL KILLER CELLS"

GENEVA, Oct. 15 -- INDAPTA THERAPEUTICS, INC. (5000 Gulf Freeway, Building 5, Room 142Houston, Texas 77023) filed a patent application (PCT/US2025/023300) for "TREATMENT OF AUTOIMMUNE DISEASES OR CONDITIONS WITH NATURAL KILLER CELLS" on Apr 04, 2025. With publication no. WO/2025/213127, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MANDL-CASHMAN, Stefanie (c/o Indapta Therapeutics, Inc.5000 Gulf Freeway, Building 5, Room 142Houston, Texas 77023), BIGLEY, Austin (c/o Indapta Therapeutics, Inc.5000 Gulf Freeway, Building ...